Revenio Group Corporation: Revenio to sell its RIB business

Report this content
Revenio Group Corporation Stock Exchange Release February 25, 2015 at 12.10
REVENIO TO SELL ITS RIB BUSINESS

Revenio  Group  Corporation  has  signed  an  agreement to sell the entire stock
capital  of Boomeranger  Boats Oy  to International  Golden Group,  domicile Abu
Dhabi, UAE. Boomeranger Boats represented RIB special boat business of Revenio's
Technology and Services segment that has been transferred to available-for-sale,
discontinued  operations.  In  line  with  its  strategy, Revenio is focusing on
health technology and sale of non-core business supports this strategy.

The  parties have agreed not to disclose the sale price. The sale of Boomeranger
Boats  that has been transferred to discontinued  operations at the end of 2014
has no impact on the Group's results. The sale is estimated to boost the Group's
cash flow by approximately three million euros.

"The sale of Boomeranger Boats secures Finnish jobs, allows the company's future
growth as well as development work to continue in Finland. We are very satisfied
to  have  a  buyer  with  a  long  term  objective  of  developing the company's
activities  and strengthening the  position of Boomeranger  Boats as the leading
company  in  its  field,"  states  Revenio  Group's President and CEO Olli-Pekka
Salovaara.

As  the CEO  of Boomeranger  Boats will  continue Mr.  Riku Lamppu  who has been
leading  the  company  since  September  2014. Along  with  the  acquisition all
personnel of Boomeranger Boats will be considered as former employees of the new
owner.

The  RIB special boats  by Boomeranger are  very reliable high-performance boats
that  are  used  in  various  demanding  patrol  and  rescue  operations  by the
authorities.  Now  completed  acquisition  is  related  to  the order of two RIB
special  boats designed for demanding conditions  that was announced in December
2014. The delivery of these two boats will take place by November 2015.

Further information:
President and CEO Olli-Pekka Salovaara, tel +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi

DISTRIBUTION:
Nasdaq Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish health tech group whose core business lies in tonometers.
The Revenio Health Tech segment comprises the business operations of Icare
Finland Oy and Oscare Medical Oy, which specializes in osteoporosis screening
and assessment. In addition, Revenio has identified new growth opportunities
relating to health tech in which common denominators are screening, follow-up
and the global need to make cost savings in health care through preventive
measures. Revenio seeks vigorous growth in health technology, both organically
and through acquisitions and mergers.

In 2014, the Revenio Group's net sales totaled MEUR 16.0, with its operating
margin for continuing operations standing at 27,5%. The Revenio Group
Corporation is listed on Nasdaq Helsinki.